litlas
Log inCreate account

Douglas L. Mann

Active 1981–2025

Also published as
Douglas L, Mann
217
Papers
52,908
Citations
113
h-index
208
i10-index

Citations

Citations per year for Douglas L. Mann1952: 1 citations1964: 2 citations1982: 6 citations1983: 5 citations1984: 27 citations1985: 27 citations1986: 18 citations1987: 21 citations1988: 12 citations1989: 12 citations1990: 10 citations1991: 18 citations1992: 32 citations1993: 26 citations1994: 17 citations1995: 42 citations1996: 69 citations1997: 148 citations1998: 165 citations1999: 202 citations2000: 299 citations2001: 273 citations2002: 369 citations2003: 331 citations2004: 368 citations2005: 352 citations2006: 372 citations2007: 340 citations2008: 403 citations2009: 409 citations2010: 393 citations2011: 386 citations2012: 366 citations2013: 339 citations2014: 375 citations2015: 425 citations2016: 442 citations2017: 474 citations2018: 465 citations2019: 1,311 citations2020: 1,537 citations2021: 1,480 citations2022: 1,247 citations2023: 952 citations2024: 1,547 citations2025: 817 citations2026: 20 citations1953–1963: no citations, so these years are not shown1965–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,788 citing papers, 27.6% of this breakdownChina: 1,768 citing papers, 8.4% of this breakdownUnited Kingdom: 1,446 citing papers, 6.9% of this breakdownGermany: 1,349 citing papers, 6.4% of this breakdownItaly: 1,111 citing papers, 5.3% of this breakdownCanada: 934 citing papers, 4.4% of this breakdownNetherlands: 750 citing papers, 3.6% of this breakdownJapan: 720 citing papers, 3.4% of this breakdownFrance: 671 citing papers, 3.2% of this breakdownAustralia: 456 citing papers, 2.2% of this breakdownSpain: 447 citing papers, 2.1% of this breakdownSwitzerland: 320 citing papers, 1.5% of this breakdown
0%27.6%Other 25%

Institutions

Fields

  • Medicine66.3%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Immunology and Microbiology9.3%
  • Neuroscience2.9%
  • Engineering2.5%
  • Computer Science0.6%
  • Other2.5%

Topics

  • Cardiovascular Function and Risk Factors5.5%
  • Heart Failure Treatment and Management5.4%
  • Cardiac Fibrosis and Remodeling5.4%
  • Cardiac Structural Anomalies and Repair1.8%
  • Cardiac electrophysiology and arrhythmias1.5%
  • Signaling Pathways in Disease1.4%
  • Other79%

Coauthors

All papers

Open in search
  1. Reappraising the role of inflammation in heart failure

    Authors: Luigi Adamo, Cibele Rocha‐Resende, Sumanth D. Prabhu, Douglas L. Mann - Nature Reviews Cardiology 2020 cited by 770

  2. Embryonic and Adult-Derived Resident Cardiac Macrophages Are Maintained through Distinct Mechanisms at Steady State and during Inflammation

    Authors: Slava Epelman, Kory J. Lavine, Anna E. Beaudin, Dorothy K. Sojka, Javier A. Carrero, Boris Calderón, Thaddeus Brija, Emmanuel L. Gautier, Stoyan Ivanov, Ansuman T. Satpathy, Joel D. Schilling, Reto A. Schwendener, Ismail Sergin, Babak Razani, E. Camilla Forsberg, Wayne M. Yokoyama, Emil R. Unanue, Marco Colonna, Gwendalyn J. Randolph, Douglas L. Mann - Immunity 2014 cited by 1,450

  3. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: Kenneth B. Margulies, Adrian F. Hernandez, Margaret M. Redfield, Michael M. Givertz, Guilherme H. Oliveira, Robert T. Cole, Douglas L. Mann, David J. Whellan, Michael S. Kiernan, G. Michael Felker, Steven E. McNulty, Kevin J. Anstrom, Monica Shah, Eugene Braunwald, Thomas P. Cappola - JAMA 2016 cited by 677

  4. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart

    Authors: Kory J. Lavine, Slava Epelman, Keita Uchida, Kassandra Weber, Colin G. Nichols, Joel D. Schilling, David M. Ornitz, Gwendalyn J. Randolph, Douglas L. Mann - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 801

  5. Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation

    Authors: Wenjun Li, Guoshuai Feng, Jason M. Gauthier, Inessa Lokshina, Ryuji Higashikubo, Sarah Evans, Xinping Liu, Adil Hassan, Satona Tanaka, Markus Cicka, Hsi-Min Hsiao, Pablo D. Pérez, Andrea Bredemeyer, Richard W. Gross, Douglas L. Mann, Yulia Y. Tyurina, Andrew E. Gelman, Valerian E. Kagan, Andreas Linkermann, Kory J. Lavine, Daniel Kreisel - Journal of Clinical Investigation 2019 cited by 504

  6. Neurohormonal activation in heart failure with reduced ejection fraction

    Authors: Justin Hartupee, Douglas L. Mann - Nature Reviews Cardiology 2016 cited by 683

  7. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

    Authors: Douglas L. Mann, John J.V. McMurray, Milton Packer, Karl Swedberg, Jeffrey Borer, Wilson S. Colucci, Jacques Djian, Helmut Drexler, Arthur M. Feldman, Lars Køber, Henry Krum, Peter Liu, Markku S. Nieminen, Luigi Tavazzi, Dirk Jan van Veldhuisen, Anders Waldenström, Marshelle Warren, Arne Westheim, Faı̈ez Zannad, Thomas R. Fleming - Circulation 2004 cited by 1,230

  8. The Seattle Heart Failure Model

    Authors: Wayne C. Levy, Dariush Mozaffarian, David T. Linker, Santosh Sutradhar, Stefan D. Anker, Anne B. Cropp, Inder S. Anand, Aldo P. Maggioni, Paul Burton, Mark D. Sullivan, Bertram Pitt, Philip A. Poole‐Wilson, Douglas L. Mann, Milton Packer - Circulation 2006 cited by 2,023

  9. Role of innate and adaptive immune mechanisms in cardiac injury and repair

    Authors: Slava Epelman, Peter P. Liu, Douglas L. Mann - Nature reviews. Immunology 2015 cited by 632

  10. Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

    Authors: Marc A. Pfeffer, Brian Claggett, Eldrin F. Lewis, Christopher B. Granger, Lars Køber, Aldo P. Maggioni, Douglas L. Mann, John J.V. McMurray, Jean-Lucien Rouleau, Scott D. Solomon, Philippe G. Steg, Otavio Berwanger, Maja Cikes, Carmine G. De Pasquale, Cara East, Alberto Fernandez, Karola Jering, Ulf Landmesser, Roxana Mehran, Béla Merkely, Freny Vaghaiwalla Mody, Mark C. Petrie, Ivo Petrov, Morten Schou, Michele Senni, David Sim, Peter van der Meer, Martin Lefkowitz, Yinong Zhou, Jianjian Gong, Eugene Braunwald - New England Journal of Medicine 2021 cited by 295

  11. Innate Immunity and the Failing Heart

    Authors: Douglas L. Mann - Circulation Research 2015 cited by 677

  12. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine

    Authors: Douglas L. Mann, Douglas P. Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald - Medical Entomology and Zoology 2011 cited by 3,780

  13. Vagus Nerve Stimulation for the Treatment of Heart Failure

    Authors: Michael R. Gold, Dirk J. van Veldhuisen, Paul J. Hauptman, Martin Borggrefe, Spencer H. Kubo, Randy Lieberman, Goran Milašinović, Brett J. Berman, Sanja Djordjević, Suresh Neelagaru, Peter J. Schwartz, G. André Ng, Douglas L. Mann - Journal of the American College of Cardiology 2016 cited by 385

  14. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

    Authors: Margaret M. Redfield, Horng H. Chen, Barry A. Borlaug, Marc J. Semigran, Kerry L. Lee, Gregory D. Lewis, Martin M. LeWinter, Jean L. Rouleau, David A. Bull, Douglas L. Mann, Anita Deswal, Lynne W. Stevenson, Michael M. Givertz, Elizabeth Ofili, Christopher M. O’Connor, G. Michael Felker, Steven R. Goldsmith, Bradley A. Bart, Steven E. McNulty, Jenny C. Ibarra, Grace Lin, Jae K. Oh, Manesh R. Patel, Raymond J. Kim, Russell P. Tracy, Eric J. Velazquez, Kevin J. Anstrom, Adrian F. Hernandez, Alice M. Mascette, Eugene Braunwald, for the RELAX Trial - JAMA 2013 cited by 1,130

  15. Heart Failure With Recovered Left Ventricular Ejection Fraction

    Authors: Jane E. Wilcox, James C. Fang, Kenneth B. Margulies, Douglas L. Mann - Journal of the American College of Cardiology 2020 cited by 314

  16. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study

    Authors: Yogesh N.V. Reddy, Gregory D. Lewis, Sanjiv J. Shah, Masaru Obokata, Omar F. Abou-Ezzedine, Marat Fudim, Jie‐Lena Sun, Hrishikesh Chakraborty, Steven E. McNulty, Martin M. LeWinter, Douglas L. Mann, Lynne W. Stevenson, Margaret M. Redfield, Barry A. Borlaug - Mayo Clinic Proceedings 2019 cited by 138

  17. Efficacy and Safety of Spironolactone in Acute Heart Failure

    Authors: Javed Butler, Kevin J. Anstrom, G. Michael Felker, Michael M. Givertz, Andreas P. Kalogeropoulos, Marvin A. Konstam, Douglas L. Mann, Kenneth B. Margulies, Steven E. McNulty, Robert J. Mentz, Margaret M. Redfield, W.H. Wilson Tang, David J. Whellan, Monica Shah, Patrice Desvigne‐Nickens, Adrian F. Hernandez, Eugene Braunwald - JAMA Cardiology 2017 cited by 306

  18. Cytokines and Cytokine Receptors in Advanced Heart Failure

    Authors: Anita Deswal, Nancy J. Petersen, Arthur M. Feldman, James B. Young, Bill G. White, Douglas L. Mann - Circulation 2001 cited by 1,007

  19. Defining cardiac functional recovery in end-stage heart failure at single-cell resolution

    Authors: Junedh Amrute, Lulu Lai, Pan Ma, Andrew L. Koenig, Kenji Kamimoto, Andrea Bredemeyer, Thirupura S. Shankar, Christoph Kuppe, Farid F. Kadyrov, Linda Schulte, Dylan Stoutenburg, Benjamin J. Kopecky, Sutip Navankasattusas, Joseph R. Visker, Samantha A. Morris, Rafael Kramann, Florian Leuschner, Douglas L. Mann, Stavros G. Drakos, Kory J. Lavine - Nature Cardiovascular Research 2023 cited by 72

  20. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation

    Authors: William T. Abraham, Karl-Heinz Kuck, Rochelle L. Goldsmith, JoAnn Lindenfeld, Vivek Y. Reddy, Peter E. Carson, Douglas L. Mann, Benjamin R. Saville, Helen Parise, Rodrigo C. Chan, Phi Wiegn, Jeffrey L. Hastings, Andrew J. Kaplan, Frank Edelmann, Lars Lüthje, Rami Kahwash, Gery Tomassoni, David D. Gutterman, Angela Stagg, Daniel Burkhoff, Gerd Hasenfuß - JACC Heart Failure 2018 cited by 267

  21. Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction

    Authors: Douglas L. Mann, Michael M. Givertz, Justin Vader, Randall C. Starling, Palak Shah, Steven E. McNulty, Kevin J. Anstrom, Kenneth B. Margulies, Michael S. Kiernan, Claudius Mahr, Divya Gupta, Margaret M. Redfield, Anuradha Lala, Gregory D. Lewis, Adam D. DeVore, Patrice Desvigne‐Nickens, Adrian F. Hernandez, Eugene Braunwald, LIFE Investigators, Selma F. Mohammed, Hellina Birru, Etsubdink Aboye, Phillip H. Lam, Nicole Escobar, Maria Cristina Domingues Fink, Thomas P. Cappola, Wendy Sheaffer, Bonitta Reilly, J W Ferree, Ashwin Ravichandran, Gina Ciezkowski, Glenda Herrera, Hirsch Mehta, Rosemarie Delucca, Sanjay Doddamani, Manreet Kanwar, B. Thomas, Laurie Machen, J. Kim, Athas Christina, Brent C. Lampert, Cindy Fontenelle, Clement Eiswirth, Julie Williams, Darlene Rock, Gregory F. Egnaczyk, Enya Rentas-Sherman, Deborah Barr, Arvind Bhimaraj, Adrianna Damato, Christine Calayo, John M. Herre, JoAnn Lindenfeld, Amanda Carroll, Mary Gordon, Mary Keebler, Bandaa Setliff, Sanjeev Gulati, K Winkler, Laura Curtin, Carly Ohmart, John Halvorson, James O. Mudd, S. Albert Camacho, Maryse Palardy, Neha Shah, Kristina Picardi, Arun Krishnamoorthy, Adrienne Maximin, Douglas Horstmanshof, Beverly Seiler, Zi J. Xu, S. Mersola, E. Kransdorf, W.H. Wilson Tang, T. Fonk, Eiran Z. Gorodeski, Guilherme H. Oliveira, Terrence Semenec, Nadine Norton, Julie Nichols, Peter Leo, Mark E. Dunlap, G. Michael Felker, Lacey D. Taylor, Mary Sheehan, Sharon Levine, Diane Cocca-Spofford, Liana Brooks, Thomas F. Cunningham, Nancy Acker, Susan Milbrandt, Janet Gatzke, Víctor G. Dávila‐Román, Anne Dirks, Karen Bult, Elizabeth Weber, Mary Lesko, Deana Mikhalkova, Kathleen Fitzgerald and 19 more - JAMA Cardiology 2021 cited by 175

  22. Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

    Authors: Brian R. Lindman, Víctor G. Dávila‐Román, Douglas L. Mann, Steven E. McNulty, Marc J. Semigran, Gregory D. Lewis, Lisa de las Fuentes, Susan Joseph, Justin Vader, Adrian F. Hernandez, Margaret M. Redfield - Journal of the American College of Cardiology 2014 cited by 210

  23. Artificial Intelligence Discusses the Role of Artificial Intelligence in Translational Medicine

    Authors: Douglas L. Mann - JACC Basic to Translational Science 2023 cited by 96

  24. The continuous heart failure spectrum: moving beyond an ejection fraction classification

    Authors: Filippos Triposkiadis, Javed Butler, François M. Abboud, Paul W. Armstrong, Stamatis Adamopoulos, J. Atherton, Johannes Backs, Johann Bauersachs, Daniel Burkhoff, Robert O. Bonow, Vijay Chopra, Rudolf A. de Boer, León J. De Windt, Nazha Hamdani, Gerd Hasenfuß, Stéphane Heymans, Jean‐Sébastien Hulot, Marvin A. Konstam, Richard Lee, Wolfgang A. Linke, Ida G. Lunde, Alexander R. Lyon, Christoph Maack, Douglas L. Mann, Alexandre Mebazaa, Robert J. Mentz, Petros Nihoyannopoulos, Zoltán Papp, John Parissis, Thierry Pedrazzini, Giuseppe Rosano, Jean L. Rouleau, Petar Seferović, Ajay M. Shah, Randall C. Starling, Carlo G. Tocchetti, Jean‐Noël Trochu, Thomas Thum, Faı̈ez Zannad, Dirk L. Brutsaert, Vincent F. M. Segers, Gilles W. De Keulenaer - European Heart Journal 2019 cited by 258